Baillière's Clinical Gastroenterology
9 Helicobacter pylori as a risk factor for cancer
References (109)
Malaria and the natural history of Helicobacter pylori infection
Lancet
(1993)- et al.
A model for gastric cancer epidemiology
Lancet
(1975) - et al.
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology
Lancet
(1991) - et al.
High incidence of primary gastric lymphoma in northeastern Italy
Lancet
(1992) - et al.
H. pylori and gastric cancer
Lancet
(1994) - et al.
Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats
Gastroenterology
(1992) - et al.
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma
Gastroenterology
(1993) - et al.
The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
Lancet
(1993) - et al.
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis
Gastroenterology
(1991) - et al.
Campylobacter pyloridis-associated chronic active antral gastritis
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia
Human Pathology
Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis
American Journal of Clinical Nutrition
Ascorbic acid in the human stomach
Gastroenterology
Gastric adenocarcinoma and Helicobacter pylori infection
Journal of the National Cancer Institute
Too many rodent carcinogens: mitogenesis increases mutagenesis
Science
Non-cardia gastric adenocarcinoma and Helicobacter pylori infection
Italian Journal of Gastroenterology
Possible role of Helicobacter pylori infection in early gastric cancer development
Cancer
The cohort effect and Helicobacter pylori
Journal of Infectious Diseases
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid
Gut
Poor housing in childhood and high rates of stomach cancer in England and Wales
British Journal of Cancer
Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach
International Journal of Cancer
Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk
Cancer Research
Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach
Cancer Research
Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence
Nutrition and Cancer
Apparent reversal of early gastric-mucosal atrophy after triple therapy for Helicobacter pylori
American Journal of Gastroenterology
Helicobacter pylori causes hyperproliferation of the gastric epithelium; pre- and post-eradication indices of proliferating cell nuclear antigen
American Journal of Gastroenterology
Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela
Cancer Causes and Control
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation
Digestive Diseases and Science
Diet, Life-style and Mortality in China
Trends in Cancer Incidence and Mortality
A human model of gastric carcinogenesis
Cancer Research
Human gastric carcinogenesis: a multistep and multifactorial process—first American cancer society award lecture on cancer epidemiology and prevention
Cancer Research
Gastric precancerous process in a high risk population: cross-sectional studies
Cancer Research
Gastric precancerous process in a high risk population: cohort follow-up
Cancer Research
Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks
Cancer
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer
Gut
Helicobacter pylori, free radicals and gastroduodenal disease
European Journal of Gastroenterology and Hepatology
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo
Gut
Helicobacter pylori and chronic gastritis
Acid, ulcers and H. pylori
Lancet
Reactive oxygen species in H. pylori infection
Reactive oxygen species (ROS) activity and damage in Helicobacter pylori associated gastritis effect of eradication therapy
Gut
Eradicating Helicobacter pylori infection lowers gastric mediated acid secretion by two-thirds in duodenal ulcer patients
Gut
Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study
European Journal of Cancer Prevention
Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only
Journal of Clinical Microbiology
Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China
International Journal of Cancer
Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation
British Medical Journal
High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis
American Journal of Gastroenterology
Ascorbate is an outstanding antioxidant in human blood plasma
Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study
Cancer Causes and Control
Cited by (60)
Anti-ulcer activity of Cyrtocarpa procera analogous to that of Amphipterygium adstringens, both assayed on the experimental gastric injury in rats
2011, Journal of EthnopharmacologyCitation Excerpt :It has also been described that Amphipterygium adstringens possesses anti-Helicobacter pylori (H. pylori) activity (Castillo-Juárez et al., 2007), an etiologic agent that plays an important role in the pathogenesis of peptic ulcer disease. Epidemiological studies have shown that areas with high gastric cancer rates often have a correspondingly high prevalence of Helicobacter pylori and prospective studies have shown that subjects with serological evidence of Helicobacter pylori infection are significantly more likely to develop gastric alterations than those without this serologic memory (Webb and Forman, 1995). Anti-Helicobacter pylori activity for Cyrtocarpa procera was also previously suggested by Castillo-Juárez et al. (2007).
Endoscopic Therapy for Gastric Neoplasms
2011, Clinical Gastrointestinal Endoscopy, Second EditionInterleukin-6 Polymorphisms, Helicobacter pylori Infection in Adult Brazilian Patients with Chronic Gastritis and Gastric Adenocarcinoma
2007, Archives of Medical ResearchCitation Excerpt :For example, noncardia gastric adenocarcinoma occurs excessively in patients with gastric atrophy and hypochlorhydria (20). The decline in incidence of noncardia gastric adenocarcinoma has paralleled the decreasing prevalence of infection with Helicobacter pylori, which plays an essential role in initiating this cancer (21). Host genetic factors are emerging as key determinants of disease risk for many cancers (22,23).
Gastric adenocarcinoma: Approach to a complex biological reality
2007, Medicina ClinicaSynthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides
2006, European Journal of Medicinal ChemistryCitation Excerpt :It is now recognized that Helicobacter pylori, an S-shaped spiral microaerophilic Gram-negative bacterium first isolated in human gastric mucosa in 1982 [1–3], is a pathogenic factor of chronic active gastritis, peptic ulcer disease, and gastric cancer [4–6] and its eradication can significantly reduce the risk of ulcer relapse and may help prevent mucosa-associated lymphoid tissue (MALT)-type gastric carcinoma and other gastric cancers [7–9].
Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives
2005, Bioorganic and Medicinal Chemistry Letters